These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1537623)

  • 1. Differential expression of the CD44 molecule in human brain tumours.
    Kuppner MC; Van Meir E; Gauthier T; Hamou MF; de Tribolet N
    Int J Cancer; 1992 Feb; 50(4):572-7. PubMed ID: 1537623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential binding of anti-CD44 on human gliomas in vitro.
    Pilkington GJ; Akinwunmi J; Ognjenovic N; Rogers JP
    Neuroreport; 1993 Mar; 4(3):259-62. PubMed ID: 8386563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variant CD44 adhesion molecules are expressed in human brain metastases but not in glioblastomas.
    Li H; Hamou MF; de Tribolet N; Jaufeerally R; Hofmann M; Diserens AC; Van Meir EG
    Cancer Res; 1993 Nov; 53(22):5345-9. PubMed ID: 7693337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative RNA splicing of the hyaluronic acid receptor CD44 in the normal human brain and in brain tumors.
    Nagasaka S; Tanabe KK; Bruner JM; Saya H; Sawaya RE; Morrison RS
    J Neurosurg; 1995 May; 82(5):858-63. PubMed ID: 7536236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein and mRNA expression of autophagy gene Beclin 1 in human brain tumours.
    Miracco C; Cosci E; Oliveri G; Luzi P; Pacenti L; Monciatti I; Mannucci S; De Nisi MC; Toscano M; Malagnino V; Falzarano SM; Pirtoli L; Tosi P
    Int J Oncol; 2007 Feb; 30(2):429-36. PubMed ID: 17203225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective expression of CD44 messenger RNA splice variants in four high grade human brain tumour cell lines.
    Harn HJ; Lee HS; Ho LI; Lee WH; Ding JH
    Biochem Mol Biol Int; 1994 Jul; 33(4):743-9. PubMed ID: 7526922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of the human metastasis adhesion molecule CD44V in normal and carcinomatous stomach mucosa of Chinese subjects.
    Harn HJ; Ho LI; Chang JY; Wu CW; Jiang SY; Lee HS; Lee WH
    Cancer; 1995 Mar; 75(5):1065-71. PubMed ID: 7531611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigens in human glioblastomas and meningiomas: Search for tumour and onco-foetal antigens. Estimation of S-100 and GFA protein.
    Dittmann L; Axelsen NH; Norgaard-Pedersen B; Bock E
    Br J Cancer; 1977 Feb; 35(2):135-41. PubMed ID: 65176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 expression in human meningiomas: An immunocytochemical, immunohistochemical and flow cytometric analysis.
    Rooprai HK; Liyanage K; King A; Davies D; Martin K; Pilkington GJ
    Int J Oncol; 1999 May; 14(5):855-60. PubMed ID: 10200334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune cell infiltration of intrinsic and metastatic intracranial tumours.
    Strik HM; Stoll M; Meyermann R
    Anticancer Res; 2004; 24(1):37-42. PubMed ID: 15015573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of somatostatin receptor subtypes in human brain tumors.
    Dutour A; Kumar U; Panetta R; Ouafik L; Fina F; Sasi R; Patel YC
    Int J Cancer; 1998 May; 76(5):620-7. PubMed ID: 9610716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and modulation of CD44 variant isoforms in humans.
    Mackay CR; Terpe HJ; Stauder R; Marston WL; Stark H; Günthert U
    J Cell Biol; 1994 Jan; 124(1-2):71-82. PubMed ID: 7507492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum adenosine deaminase activity in brain tumours.
    Manjula S; Raja A; Rao SN; Aroor AR; Rao A
    Acta Neurochir (Wien); 1993; 121(3-4):149-51. PubMed ID: 8512012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shedding of the CD44 adhesion molecule from leukocytes induced by anti-CD44 monoclonal antibody simulating the effect of a natural receptor ligand.
    Bazil V; Horejsí V
    J Immunol; 1992 Aug; 149(3):747-53. PubMed ID: 1634766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Confirmation by peptide sequence and co-expression on various cell types of the identity of CD44 and P85 glycoprotein.
    Quackenbush EJ; Vera S; Greaves A; Letarte M
    Mol Immunol; 1990 Oct; 27(10):947-55. PubMed ID: 2233756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphological, immunocytochemical and flow cytometric in vitro characterisation of a surface-adherent medulloblastoma.
    Parker K; Pilkington GJ
    Anticancer Res; 2005; 25(6B):3855-63. PubMed ID: 16309171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophages in experimental and human brain tumors. Part 2: studies of the macrophage content of human brain tumors.
    Morantz RA; Wood GW; Foster M; Clark M; Gollahon K
    J Neurosurg; 1979 Mar; 50(3):305-11. PubMed ID: 422981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody ONS-M21 recognizes integrin alpha3 in gliomas and medulloblastomas.
    Kishima H; Shimizu K; Tamura K; Miyao Y; Mabuchi E; Tominaga E; Matsuzaki J; Hayakawa T
    Br J Cancer; 1999 Jan; 79(2):333-9. PubMed ID: 9888477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44 expression on activated B cells. Differential capacity for CD44-dependent binding to hyaluronic acid.
    Hathcock KS; Hirano H; Murakami S; Hodes RJ
    J Immunol; 1993 Dec; 151(12):6712-22. PubMed ID: 7505013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Various immunological parameters studied in patients with malignant brain tumor. Correlation between clinical stage and T cell subsets].
    Inoue I; Yoshida J; Kato K; Wakabayashi T; Kobayashi T; Kageyama N
    Neurol Med Chir (Tokyo); 1985 Mar; 25(3):168-76. PubMed ID: 2409460
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.